Sorafenib Related Compound7
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

2206827-12-3Sorafenib Related Compound7

● In Stock

Catalogue No.:VL2020006
CAS No.:2206827-12-3
Mol. Formula:C16H17N3O4
Mol. Weight:315.33 g/mol

Additional information on CAS 2206827-12-3

Parent drug

Sorafenib

IUPAC Name

Ethyl 4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenylcarbamate

Synonyms

N/A

Smiles

CCOC(=O)NC1=CC=C(C=C1)OC2=CC(=NC=C2)C(=O)NC

Description

Sorafenib Related Compound 7 (CAS No: 2206827-12-3) Or ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate, Sorafenib is a protein kinase inhibitor with activity against many protein kinases, which is used to treat kidney, liver, and thyroid cancer.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url